Amlodipine reduces cyclosporin-induced hyperuricaemia in hypertensive renal transplant recipients

被引:64
作者
Chanard, J
Toupance, O
Lavaud, S
de Ligny, BH
Bernaud, C
Moulin, B
机构
[1] CHU Hop Maison Blanche, Serv Nephrol, Reims, France
[2] CHU Hop Clemenceau, Serv Nephrol Dialyse & Transplantat, Caen, France
[3] Pfizer SA, Paris, France
[4] CHU Hop Civil, Serv Nephrol, Strasbourg, France
关键词
amlodipine; calcium channel blockade; cyclosporin A; gout; hyperuricaemia; renal transplantation;
D O I
10.1093/ndt/gfg341
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Hypertension and hyperuricaemia are common side-effects of cyclosporin A (CsA) treatment in renal transplant recipients. While it is well established that the calcium channel blocker amlodipine can control CsA-induced hypertension effectively in this patient population, recent evidence suggests amlodipine might also reduce hyperuricaemia. The present study was designed to compare the effects of the calcium channel blocker amlodipine (5-10mg/day) and the beta-adrenoceptor antagonist tertatolol (5-10mg/day) on CsA-induced hyperuricaemia in post-renal transplant recipients with hypertension. Methods. Forty-eight hypertensive renal transplant recipients on a stable dose of CsA were randomized in a double-blind, parallel-group manner to receive either amlodipine (n = 24) or tertatolol (n = 24) for 60 days. The primary outcome measure was the change from baseline in serum uric acid concentration. Secondary analyses of efficacy were based on changes in renal function and blood pressure. Results. Amlodipine significantly decreased serum uric acid levels from 483 +/- 99 to 431 +/- 10 mumol/l (P < 0.001), while tertatolol significantly increased uric acid from 450 98 to 476 84 mumol/l (P = 0.006). Amlodipine also significantly increased glomerular filtration rate (P = 0.0048) and the clearance rate of uric acid (P=0.023) and it reduced the fractional proximal tubular reabsorption of sodium (P < 0.001), compared with tertatolol. Renal plasma flow and filtered fraction were unaffected by both treatments, as was trough CsA blood concentration. Amlodipine lowered systolic blood pressure to a significantly greater extent than did tertatolol (P=0.007). The time-dependent profile of diastolic blood pressure did not differ significantly between treatment groups. Both drugs were well tolerated. Conclusions. Amlodipine could be more appropriate than tertatolol for CsA-induced hypertension and hyperuricaemia in renal transplant recipients.
引用
收藏
页码:2147 / 2153
页数:7
相关论文
共 20 条
  • [2] Renal and systemic effects of atenolol and tertatolol in renal transplant recipients on cyclosporine A
    Branten, AJW
    Hilbrands, LB
    van Hamersvelt, HW
    Koene, RAP
    Huysmans, FTM
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (02) : 423 - 426
  • [3] Clive DM, 2000, J AM SOC NEPHROL, V11, P974, DOI 10.1681/ASN.V115974
  • [4] ACUTE EFFECTS OF NIFEDIPINE IN RENAL-TRANSPLANT RECIPIENTS TREATED WITH CYCLOSPORINE OR AZATHIOPRINE
    HILBRANDS, LB
    HOITSMA, AJ
    VANHAMERSVELT, HW
    WETZELS, JFM
    HUYSMANS, FTM
    KOENE, RAP
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 24 (05) : 838 - 845
  • [5] Iñigo P, 2001, J AM SOC NEPHROL, V12, P822, DOI 10.1681/ASN.V124822
  • [6] Uricosuric effect of losartan in patients with renal transplants
    Kamper, AL
    Nielsen, AH
    [J]. TRANSPLANTATION, 2001, 72 (04) : 671 - 674
  • [7] Krusell Lars Romer, 1997, Blood Pressure, V6, P166, DOI 10.3109/08037059709061933
  • [8] Mechanisms of hyperuricemia in cyclosporine-treated renal transplanted children
    Laine, J
    Holmberg, C
    [J]. NEPHRON, 1996, 74 (02): : 318 - 323
  • [9] IMPAIRMENT OF TUBULAR SECRETION OF URATE IN RENAL-TRANSPLANT PATIENTS ON CYCLOSPORINE
    MARCEN, R
    GALLEGO, N
    OROFINO, L
    GAMEZ, C
    ESTEPA, MR
    SABATER, J
    TERUEL, JL
    ORTUNO, J
    [J]. NEPHRON, 1995, 70 (03): : 307 - 313
  • [10] Martinez AM, 1996, GASTROENTEROLOGY, V110, pA1259